Home » Topics » Conferences

Conferences
RSS

TransVax reduces cytomegalovirus viremia in phase II trial

Oct. 1, 2010

Phase II data show efficacy of Gilead Sciences' Quad anti-HIV regimen through 48 weeks

Oct. 1, 2010

QTc interval is prolonged in myotonic dystrophy type 1 / News in Context

Oct. 1, 2010

CONQUER trial reveals benefits of phentermine/topiramate combination in obesity

Sep. 30, 2010

ARRY-502 well tolerated in phase I study

Sep. 30, 2010

VP-20621 generally well tolerated in phase I study

Sep. 30, 2010

Scientists describe CFTR inhibitors for acute secretory diarrhea

Sep. 30, 2010

Clinical data presented on DiaPep-277 in type 1 diabetes

Sep. 30, 2010

Studies point to potential benefit of ITI-007 in Parkinson's disease

Sep. 29, 2010

SUN-13834 is efficacious in patients with atopic dermatitis

Sep. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...